Skip to content
Lower risk Medical device recall · FDA · Published February 14, 2023

Brainlab ExacTrac Software Recall: DIBH Functionality May Not Work Correctly

Brainlab recalls ExacTrac Dynamic software models 20910-01E and 20910-01F (versions 1.1.0-1.1.1) due to potential DIBH functionality issues in radiation therapy workflows.

🇺🇸 FDA recall #Z-1259-2023Medical deviceBrainlab ›
Take action

Contact the company

Recalling firmBrainlab AGOlof-palme-str. 9 · Munich, Germany
✎ GovInfoNow plain-language explainer

What happened, in plain English

Brainlab is recalling specific software versions for radiation therapy systems because the Deep Inspiration Breath Hold feature might not function properly during standard treatment templates. This could affect treatment accuracy if the software doesn't respond correctly to breathing patterns. Read more at govinfonow.com/recall/58893-brainlab-exactrac-software-recall-dibh-functionality-may-not-work-correctly.

Source Summary by GovInfoNow · govinfonow.com/recall/58893-brainlab-exactrac-software-recall-dibh-functionality-may-not-work-correctly · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1259-2023

Cite this page

“Brainlab ExacTrac Software Recall: DIBH Functionality May Not Work Correctly.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/58893-brainlab-exactrac-software-recall-dibh-functionality-may-not-work-correctly. Based on FDA recall #Z-1259-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1259-2023%22&limit=1).

Why it’s dangerous

The software's Deep Inspiration Breath Hold feature may not work as intended when following standard treatment templates. This could lead to inaccurate radiation delivery if the system doesn't properly track breathing patterns during treatment.

Who’s affected

Patients receiving radiation therapy using Brainlab ExacTrac systems with the recalled software versions are most at risk. Healthcare providers using these systems for treatment planning may also be affected.

How to tell if you have this one

Check if your Brainlab ExacTrac system has software versions 1.1.0 or 1.1.1. The product was sold with GTIN 04056481143978 and models 20910-01E or 20910-01F.

  • Brand
    Brainlab
  • Product
    Brainlab ExacTrac Dynamic software, Medical Charged-Particle Radiation Therapy System, model 20910-01E and 20910-01F
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Verify your software version by checking the system settings or documentation for versions 1.1.0 or 1.1.1.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 23 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: nationwideMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: named in the noticeORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: nationwideOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: named in the noticeCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: nationwideALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution in the states of AZ, AR, CA, CO, FL, GA. IL, IN, KY, LA, MS, MO, NJ, NY, NC, ND, OK, OR, PA, TN, TX, VA, and WA. There was no government/military distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Jersey, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Washington.

Recall timeline

FDA published this recall 36 days after the firm started it.

1. Firm started the recall: Feb 14, 202312. FDA classified it Class II: Mar 16, 202323. Published in FDA’s Enforcement Report: Mar 22, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1259-2023 (February 14, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1259-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA